While many human cancers such as advanced melanoma showed impressive response to treatment with immune checkpoint inhibitors, patients with pancreatic cancer did not respond to immunological checkpoint antagonists, although cancer cell-specific CD8+ T cells were certainly present [41, 42]. Here, CD8A is linked to pancreatic neoplasm.